DERMAL FILLERS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

Global Dermal Fillers Market Size and Forecast – 2025 to 2032

The Global Dermal Fillers Market is estimated to be valued at USD 5.12 Bn in 2025 and is expected to reach USD 10.97 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 11.5% from 2025 to 2032. This significant expansion is driven by increased consumer demand for minimally invasive cosmetic procedures and rising awareness about aesthetic enhancements worldwide. The market growth is also supported by technological advancements and the availability of innovative filler products with improved safety profiles.

Key Takeaways of the Global Dermal Fillers Market

• Hyaluronic acid is expected to dominate the global dermal fillers market, capturing 35.2% of the market share by 2025 due to its excellent combination of patient safety and aesthetic effectiveness.
• Facial wrinkle treatment is the largest segment, holding an estimated 23. 4% share in 2025, driven by the rising demand for youthful appearances and the growing preference for minimally invasive cosmetic procedures worldwide.
• Biodegradable/absorbable fillers will lead the product type segment, accounting for an estimated 55. 3% of the market share in 2025.
• North America is expected to lead the market, holding a share of 38. 3% in 2025. Asia Pacific is anticipated to be the fastest-growing region, with a market share of 23.2% in 2025.

Market Overview

Current market trends indicate a growing preference for hyaluronic acid-based dermal fillers due to their efficacy and reduced side effects. Additionally, there is an increasing adoption of personalized aesthetic treatments tailored to individual needs, driving demand. The rise of social media influence and the growing number of cosmetic clinics globally are further propelling market growth. Additionally, emerging markets are witnessing rapid growth due to improved healthcare infrastructure and rising disposable incomes, fueling greater access to medical aesthetic procedures.

Currents Events and their Impact

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Segmental Insights

To learn more about this report, Download Free Sample

Dermal Fillers Market Insights, By Material Type - Hyaluronic acid contributes the highest share of the market owing to its biocompatibility and versatile cosmetic benefits

Hyaluronic acid is expected to dominate the global dermal fillers market with a share of 35.2% in 2025 by material type due to its exceptional properties that align well with both patient safety and aesthetic effectiveness. Hyaluronic acid (HA) is a naturally occurring polysaccharide found in the human body, which significantly reduces the risk of adverse reactions or allergic responses when used as a dermal filler. This inherent biocompatibility makes hyaluronic acid fillers highly preferred by clinicians and consumers alike.

Another driving factor behind HA’s market leadership is its capability to deliver immediate volumizing effects and hydration to the skin. Since HA attracts and retains water molecules, it not only restores lost volume but also rejuvenates the skin’s texture and elasticity, producing natural-looking results.

In March 2021, Royal DSM launched the HYA-ACT range, expanding its hyaluronic acid filler portfolio to meet the growing demand for non-invasive beauty solutions. The new line includes three forms of hyaluronic acid, designed for use in dermal fillers and other cosmetic treatments. This expansion reflects the increasing market interest in hyaluronic acid, which is used in 78% of U.S. dermal filler procedures and has seen a 55% rise in product launches between 2017 and 2019.

Dermal Fillers Market Insights, By Application - Facial wrinkle treatment leads the market driven by increasing aesthetic awareness and demand for non-surgical anti-aging solutions

Facial wrinkle treatment holds the largest segmental share in the dermal fillers market with an estimated share of 23.4% in 2025 due to a growing emphasis on youthful appearance and the shift towards minimally invasive cosmetic procedures globally. As the global population ages and the desire to maintain a youthful look increases across all age groups, consumers are increasingly opting for treatments specifically targeting dynamic and static wrinkles.

The rise in facial wrinkles, both fine lines and deeper furrows, caused by intrinsic aging and environmental factors, such as UV exposure, has created sustained demand for effective wrinkle management solutions. Dermal fillers used for wrinkle treatment provide a quick, non-surgical approach to smoothing out these signs of aging, offering an alternative to more invasive surgical procedures which often carry higher risks and longer recovery times.

Dermal Fillers Market Insights, By Product Type - Biodegradable/absorbable fillers dominate due to safety profile and regulatory acceptance

Biodegradable/absorbable fillers account for the highest market share within the product type segment with an estimated share of 55.3% in 2025, largely because of their superior safety and acceptance across global regulatory bodies. These fillers are designed to be gradually metabolized by the body after fulfilling their aesthetic purpose, offering a temporary yet effective solution for facial rejuvenation. This feature addresses patient concerns about permanence and potential complications tied to non-absorbable alternatives.

The preference for biodegradable fillers is driven by the increasing focus on safety and risk minimization in cosmetic treatments. Unlike permanent fillers, which can cause long-term adverse effects such as granulomas or migration, absorbable fillers provide a non-permanent solution that allows patients to reassess their aesthetic goals and adapt treatments over time without enduring irreversible changes.

Regional Insights

To learn more about this report, Download Free Sample

North America Dermal Fillers Market Analysis and Trends

In North America, the dominance in the global dermal fillers market stems from a mature healthcare infrastructure combined with high consumer awareness regarding aesthetic treatments with an estimated share of 38.3% in 2025. The region benefits from well-established regulatory frameworks, particularly the U.S. FDA’s stringent guidelines, which has helped ensure the safety and efficacy of dermal filler products.

The presence of leading market players such as Allergan (a subsidiary of AbbVie), Ipsen, and Revance Therapeutics fosters innovation and widespread product availability. Furthermore, robust healthcare reimbursement policies, coupled with the cultural acceptance of cosmetic procedures, contribute to sustained demand.

For instance, in May 2023, Cartessa Aesthetics, known for pioneering aesthetic technologies, introduced a new dermal filler solution to the North America dermal fillers market. This innovative product combines hyaluronic acid-based fillers with advanced cross-linking technology to enhance treatment versatility. The new dermal filler provides improved skin volumization and longer-lasting results, targeting consumers looking for effective, non-invasive facial rejuvenation solutions.

Asia Pacific Dermal Fillers Market Analysis and Trends

Meanwhile, the Asia Pacific region is expected to exhibit the fastest growth in the dermal fillers market with a share of 23.2% in 2025 due to rapidly expanding urban populations with rising disposable incomes and increasing interest in cosmetic enhancements. Countries like South Korea, Japan, and China have witnessed a surge in medical tourism, driven by advancements in aesthetic medicine and competitive pricing.

Government initiatives supporting healthcare modernization and regulatory streamlining have also strengthened market dynamics. Notable companies such as LG Chem and Mentor (a Johnson & Johnson company) actively participate in this market, promoting local manufacturing and distribution of dermal fillers. The growing influencer culture and the normalization of minimally invasive cosmetic procedures further accelerate demand. Additionally, expanding e-commerce platforms enhance product accessibility, especially in emerging economies within the region.

Dermal Fillers Market Outlook for Key Countries

U.S. Dermal Fillers Market Trends

The U.S. dermal fillers market is highly developed and competitive, with major players like Allergan and Revance Therapeutics leading the way through continuous product innovation and strategic marketing. The strong presence of specialty clinics and aesthetic centers ensures widespread adoption of dermal fillers. Regulatory support from the U.S. FDA and favorable reimbursement policies pave the way for rapid product approvals and market penetration. Additionally, the country's consumer base remains highly engaged with aesthetic trends, contributing to ongoing demand for advanced dermal filler formulations.

In July 2024, Allergan Aesthetics announced that its innovative dermal filler, Juvéderm Skinvive, has received U.S. FDA approval. Skinvive is a unique “microdroplet” injectable designed to improve skin smoothness and hydration, rather than augmenting features or correcting wrinkles. The filler is injected using numerous small points across the treatment area, allowing it to diffuse within the skin for a natural glow.

U.K. Dermal Fillers Market Trends

The U.K. dermal fillers market is growing rapidly, driven by increasing demand for non-surgical aesthetic treatments. Hyaluronic acid fillers dominate due to their safety and natural results, while alternatives like calcium hydroxylapatite and poly-L-lactic acid are gaining traction. Millennials, particularly those aged 26–34, represent the largest demographic for dermal fillers, influenced by social media and celebrity endorsements. However, the market faces challenges such as unregulated practices and safety concerns, prompting calls for stricter regulations to ensure treatment quality and consumer protection.

In July 2022, the Scottish government considered new regulations to enhance public safety around non-surgical cosmetic procedures, such as dermal fillers. Following a consultation, which saw 98% of respondents support tighter regulations, the government is planning measures that would restrict who can administer dermal fillers. The new rules would ensure that only trained and qualified healthcare professionals conduct these procedures, with strict hygiene and clinical standards.

South Korea Dermal Fillers Market Trends

South Korea continues to lead as a global hub for cosmetic procedures, including dermal fillers, due to its cutting-edge aesthetic technology and strong cultural emphasis on beauty. The government’s support for medical innovation and medical tourism has elevated the country’s market. Domestic companies like LG Chem drive product development while international players also maintain a presence. South Korea’s highly skilled medical professionals and well-established clinics further boost the demand for diverse and advanced dermal filler options, making it a critical center for market growth and innovation in the Asia Pacific region.

In March 2021, Joonghun Pharmaceutical, a South Korean company specializing in hyaluronic acid injections for orthopedic treatments, launched Artgaon, a premium cross-linked hyaluronic acid dermal filler. Certified with the CE mark, Artgaon is aimed at the European aesthetic market, focusing on high-quality production and unique cross-linking technology. Manufactured under strict pharmaceutical guidelines, Artgaon is created in cleanrooms with particle control, ensuring exceptional safety and quality.

China Dermal Fillers Market Trends

China’s dermal fillers market is rapidly evolving, driven by increasing urbanization and rising consumer interest in aesthetic treatments. The government’s efforts to streamline medical regulations and promote healthcare innovation have fostered a conducive environment for market growth. Both multinational companies like Allergan and local firms play significant roles, with emphasis on product customization to fit regional preferences. The proliferation of beauty salons, clinics, and online sales channels further enhances accessibility. China’s expanding middle class and growing awareness of cosmetic procedures underscore its importance as a key market within the Asia Pacific region.

In June 2023, Croma-Pharma, a leading provider of medical aesthetic products, announced the enrollment of the first patient in a clinical trial for its hyaluronic acid dermal filler, Princess Volume Plus Lidocaine, in China. The Phase 3 trial, aimed at assessing the efficacy and safety of the product for mid-facial volume restoration, will involve 600 patients across 15 clinical centers. This trial is part of Croma's joint venture with Lanhzou Biotechnique Development, a subsidiary of Sinopharm, to expand its aesthetic product portfolio in China and Hong Kong.

End User Feedback and Unmet Needs in the Global Dermal Fillers Market

• End users in the global dermal fillers market, particularly those in aesthetic clinics and cosmetic dermatology practices, provide mixed feedback on product performance and accessibility. A key positive highlight is the high satisfaction with the ease of use and natural-looking results provided by hyaluronic acid-based fillers. For example, many patients and practitioners have praised products like Restylane and Juvederm for their ability to restore facial volume and smooth wrinkles with minimal downtime, allowing clinics to offer efficient, effective treatments that meet patient expectations. These features, combined with relatively quick recovery times, are frequently cited as major advantages in patient satisfaction, fostering strong customer retention and repeat business.
• However, concerns persist regarding the high cost and limited customization options of dermal fillers. Users have expressed frustration over the inability to tailor fillers to meet diverse skin types or specific facial structures. While some brands have incorporated improved formulations, many end-users report challenges in achieving personalized results, especially for clients with unique aesthetic needs. This limitation points to an unmet need for more customizable filler solutions, with greater versatility in formulation for different skin types or facial areas.
• Furthermore, affordability remains a key issue for both consumers and clinics, as the cost of high-quality dermal fillers can be prohibitive for many potential patients. Addressing these needs through the development of more affordable, customizable, and adaptable fillers could not only enhance patient satisfaction but also create growth opportunities by expanding access to a broader consumer base, ultimately driving innovation and long-term market expansion.

Market Players, Key Developments, and Competitive Intelligence

To learn more about this report, Download Free Sample

Key Developments

• On August 5, 2025, Atelier Aesthetics, a new beauty-enhancing practice located at 8801 SW 136 St. in Miami, celebrated its grand opening on May 1, 2025. Co-founded by licensed aesthetician Mrs. Savannah Roberts, the clinic specializes in advanced, minimally invasive treatments to rejuvenate skin, refine facial contours, and restore volume. Popular services include Botox, Dysport, hyaluronic acid fillers, Sculptra, Skinvive, Kybella, and laser treatments.
• In February 2025, Evolus, Inc., a company specializing in aesthetic treatments, received U.S. FDA approval for its first hyaluronic acid dermal fillers, Evolysse Form and Evolysse Smooth. These new injectable gels expand Evolus's presence in the dermal fillers market. The products, developed for the treatment of nasolabial folds, were proven to be safe and effective in a pivotal study involving 140 participants. The fillers offer versatility, allowing practitioners to inject at varying depths, resulting in natural-looking outcomes with high patient satisfaction.
• In June 2024, SYMATESE announced the submission of its Premarket Approval (PMA) application to the U.S. FDA for its EVOLYSSE LIFT and EVOLYSSE SMOOTH hyaluronic acid dermal fillers. The fillers are designed for the treatment of nasolabial folds (NLF), with approval expected in the second half of 2025. The submission is based on the results of a U.S. pivotal study that evaluated the safety and efficacy of the products in a controlled trial with 140 patients. This marks a significant step following the company’s 2023 agreement with EVOLUS.
• In January 2024, Galderma, a global leader in dermatology, received Health Canada approval for Restylane SHAYPE, a hyaluronic acid injectable designed for deep chin augmentation. Powered by NASHA HD technology, Restylane SHAYPE mimics bone structure, providing a firm, natural-looking effect. This new addition to the Restylane portfolio is the first non-surgical solution for chin enhancement, offering an alternative to implants. It will be available in Canada providing a new option for those seeking to improve chin definition and facial balance.

Top Strategies Followed by Global Dermal Fillers Market Players

• Established market leaders, typically large multinational corporations, heavily invest in research and development (R&D) to drive innovation and deliver high-performance dermal filler products. This commitment to innovation allows them to meet evolving consumer demands for safety, efficacy, and longer-lasting results. Moreover, these players strategically form partnerships and alliances with major industry stakeholders, including original equipment manufacturers (OEMs), biotechnology firms, and distribution giants, thereby solidifying their foothold in the market.
  • In September 2023, Galderma, a pharmaceutical company, announced that its new injectable dermal filler, Restylane Eyelight, has received U.S. FDA approval for treating under-eye volume loss, also known as infraorbital hollowing. This hyaluronic acid-based filler is designed for adults over 21 and helps reduce the appearance of under-eye bags and dark circles. Unique for its use of Non-Animal Stabilized Hyaluronic Acid (NASHA), Restylane Eyelight offers longer-lasting results compared to traditional fillers, due to its reduced immune response and slower breakdown.

• Mid-level players in the dermal fillers market focus on providing affordable products while maintaining a strong commitment to quality, targeting price-sensitive consumers who seek effective, budget-friendly solutions. These companies often partner with established manufacturers or technology providers to enhance production capabilities and leverage the latest advancements in dermal filler technology.
  • Medytox, a South Korean biopharmaceutical company, is another example. It focuses on providing cost-effective dermal filler solutions such as Innotox, a botulinum toxin-based product. They focus on affordable products while maintaining high standards of quality, often collaborating with global distributors to extend their market reach.

• Small-scale players in the global dermal fillers market often differentiate themselves by focusing on niche segments and product differentiation rooted in innovation. By targeting specialized features—such as organic or natural ingredient formulations, customizable filler solutions, or products designed for specific demographics—these companies stand out in a crowded marketplace. They frequently adopt cutting-edge technologies, including novel bioengineering methods and digital customization tools, to develop unique offerings that appeal to distinct consumer needs.
  • For example, Medytox, a smaller player in the dermal fillers industry, offers products like Innotox, a botulinum toxin-based filler, tailored for specific aesthetic needs. Another example is Revance Therapeutics, which has developed DaxibotulinumtoxinA (Daxi), a novel injectable botulinum toxin aimed at reducing facial wrinkles with a longer-lasting effect compared to traditional treatments. These companies leverage advanced technologies, such as bioengineering and digital customization tools, to cater to distinct consumer demands.

Market Report Scope

Dermal Fillers Market Report Coverage

Dermal Fillers Market Dynamics

To learn more about this report, Download Free Sample

Dermal Fillers Market Driver - Rising Demand for Minimally Invasive Cosmetic Procedures

The increasing preference for minimally invasive cosmetic procedures is a significant driver fueling the expansion of the global dermal fillers market. Consumers today are seeking aesthetic treatments that offer effective results without the risks, downtime, and discomfort associated with traditional surgical interventions. Dermal fillers fit this demand perfectly as they provide immediate enhancement, require minimal recovery time, and have a relatively low risk of complications. Additionally, the growing awareness of self-care, personal grooming, and the desire to maintain a youthful appearance across various age groups have contributed to the acceptance of injectable treatments. The convenience and rapid nature of these procedures make them appealing to busy individuals who want to improve facial contours, reduce wrinkles, or restore volume without interrupting their daily routines.

In May 2025, The Laser Lounge Spa, Sarasota’s leading medical spa, introduced a range of medical-grade, non-surgical treatments to meet the growing demand for advanced skincare and aesthetic solutions. With a focus on safety and professionalism, the spa blends cutting-edge technology with expert clinical care to deliver personalized treatments. Popular offerings include injectable enhancements like lip fillers, which restore facial balance and smooth wrinkles, enhancing natural features and rejuvenating the skin. Each service is tailored through consultations and medical reviews, ensuring noticeable and long-lasting results.

Dermal Fillers Market Opportunity - Technological Advancements in Injectable Fillers

The global dermal fillers market stands at the cusp of significant growth driven by rapid technological advancements in injectable filler formulations and delivery methods. Innovations such as the development of biocompatible, longer-lasting hyaluronic acid-based fillers and the introduction of novel ingredients like poly-L-lactic acid and calcium hydroxylapatite have enhanced product efficacy and safety profiles, thereby increasing consumer trust and adoption rates. Additionally, advancements in precision injection devices and techniques have improved the accuracy of filler placement, minimized side effects and promoted natural-looking results. The integration of nanotechnology and bioengineering is further propelling the creation of customized, patient-specific filler solutions that address a broader range of aesthetic concerns, including fine lines, volume loss, and skin texture improvement. Moreover, the rise of minimally invasive procedures supported by these technological improvements is expanding the target demographic by attracting younger consumers interested in preventive anti-aging treatments alongside older adults seeking facial rejuvenation.

For instance, in November 2023, Venus Concept Inc., a global leader in medical aesthetic technology, launched Venus Versa Pro in the U.S. This new multi-application platform supports 10 applicators for treating skin texture, acne, wrinkles, pigmentation, and dermal fillers. Building on the Venus VivaMD system, it enhances ablation and coagulation for improved skin resurfacing. The device also features the signature TriBella treatment, combining (MP)², IPL, and NanoFractional RF technologies for comprehensive skin rejuvenation, along with injectable dermal fillers for volume restoration and wrinkle smoothing.

Analyst Opinion (Expert Opinion)

• The dermal fillers market is experiencing robust growth, driven by technological advancements in injectable formulations and the rising demand for non-invasive cosmetic procedures. Key driving factors include the increasing consumer preference for minimally invasive treatments, advancements in hyaluronic acid-based fillers, and regulatory support for product safety and efficacy. The market is further supported by an aging population and the growing acceptance of aesthetic procedures across both genders. However, the market faces challenges such as regulatory hurdles, competition from biosimilars, and the need for skilled practitioners to ensure safety and optimal results. Emerging opportunities exist in the development of next-generation fillers with longer-lasting effects and enhanced safety profiles, while challenges around product counterfeiting and consumer awareness persist.
• In recent years, conferences like the International Society of Aesthetic Plastic Surgery (ISAPS) and Dermal Filler Summit have significantly contributed to advancing the dermal filler industry. These events provide a platform for knowledge-sharing, technological showcases, and policy discussions that impact market trends and consumer safety standards. For example, the 2023 ISAPS Global Aesthetic Conference brought together experts to discuss innovations and regulatory practices in dermal fillers. Additionally, industry initiatives like the launch of All You NEEDLE to Know by Nita McHugh are helping educate both consumers and injectors, promoting transparency and informed decision-making.

Market Segmentation

• Material Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Hyaluronic Acid
  • Calcium Hydroxylapatite
  • Poly-L-lactic Acid
  • Polymethylmethacrylate
  • Fat Fillers (Autologous Fat Transfer)
  • Others (Collagen)
• Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Facial Wrinkle Treatment
  • Volume Loss Treatment
  • Facial Contouring
  • Lip Enhancement
  • Scar Treatment
  • Other Cosmetic Applications
• Product Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Biodegradable/Absorbable Fillers
  • Non-Biodegradable Fillers
• Gender Insights (Revenue, USD Bn, 2020 - 2032)
  • Female
  • Male
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Cosmetic Clinics
  • Dermatology Clinics
  • Hospitals
  • Homecare Settings
  • Others (Medical Spa)
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Allergan (AbbVie)
  • Revance Therapeutics, Inc.
  • Ipsen
  • Merz Pharmaceuticals
  • Medytox, Inc.
  • Galderma
  • Hugel, Inc.
  • Anika Therapeutics, Inc.
  • Bioxis Pharmaceuticals
  • Prollenium Medical Technologies
  • Sinclair Pharma
  • LG Chem
  • TEOXANE
  • RHA Collection (Revance Therapeutics)
  • Carefill

Sources

Primary Research Interviews

• Industry Stakeholders List
  • Aesthetic Physicians and Dermatologists
  • Cosmetic Surgeons
  • Medical Directors in Aesthetic Clinics
  • Manufacturers of Dermal Fillers
  • Healthcare Providers in Aesthetic Medicine
• End-users List
  • Consumers receiving aesthetic treatments
  • Clinics and Dermatology Centers
  • Hospitals with aesthetic departments
  • Non-surgical aesthetic treatment centers

Government and International Databases

• U.S. Food and Drug Administration (FDA)
• European Medicines Agency (EMA)
• World Health Organization (WHO)
• Centers for Disease Control and Prevention (CDC)
• Health Canada
• Medicines and Healthcare Products Regulatory Agency (MHRA) UK
• National Institutes of Health (NIH)

Trade Publications

• Aesthetic Surgery Journal
• Journal of Clinical and Aesthetic Dermatology
• Dermatologic Surgery
• Plastic and Reconstructive Surgery Journal
• Journal of Cosmetic Dermatology
• International Journal of Dermatology
• Aesthetic Medicine Journal

Academic Journals

• Dermatologic Surgery
• Journal of Cosmetic Dermatology
• Plastic and Reconstructive Surgery
• International Journal of Aesthetic and Anti-Aging Medicine
• Journal of Drugs in Dermatology
• Journal of Dermatology
• Journal of Aesthetic and Reconstructive Surgery

Reputable Newspapers

• The New York Times
• The Guardian
• The Wall Street Journal
• The Financial Times
• The Washington Post
• Los Angeles Times

Industry Associations

• International Society of Aesthetic Plastic Surgery (ISAPS)
• American Society for Aesthetic Plastic Surgery (ASAPS)
• European Society of Aesthetic Surgery (ESAS)
• British Association of Aesthetic Plastic Surgeons (BAAPS)
• American Academy of Dermatology (AAD)
• American Society of Dermatologic Surgery (ASDS)
• International Federation of Plastic, Reconstructive, and Aesthetic Surgery (IPRAS)

Public Domain Resources

• National Institutes of Health (NIH)
• National Center for Biotechnology Information (NCBI)
• U.S. National Library of Medicine (NLM)
• World Bank Open Data
• OECD Health Statistics

Proprietary Elements

• CMI Data Analytics Tool Proprietary analytics tool to analyze real-time market trends, consumer behavior, and technology adoption in market
• Proprietary CMI Existing Repository of Information for Last 8 Years